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Summary
 
The goal of this study was to determine the mechanisms by which dendritic cells (DCs) in
blood could interact with endothelium, a prerequisite to extravasation into tissues. Our results
indicate that DCs express both HECA-452–reactive and nonreactive isoforms of P-selectin
glycoprotein ligand 1 (PSGL-1) and can tether and roll efficiently on E- and P-selectin under
flow conditions in vitro. Freshly isolated blood DCs were further observed to roll continuously
along noninflamed murine dermal endothelium in vivo. This interaction is strictly dependent
on endothelial selectins, as shown by experiments with blocking antibodies and with E- and
P-selectin–deficient mice. We hypothesize that DCs in blood are constitutively poised at the
interface of blood and skin, ready to extravasate upon induction of inflammation, and we
showed that cutaneous inflammation results in a rapid recruitment of DCs from the blood to
tissues. We propose that this is an important and previously unappreciated element of immu-
nosurveillance.
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I
 
n the years since their initial description, the central role
of dendritic cells (DCs)
 
1
 
 in the development of acquired
immune responses has become widely accepted (1, 2). Tis-
sue DCs, particularly those in tissues which constitute epi-
thelial interfaces with the environment, capture antigens
and migrate to lymphoid organs, where they present anti-
gens to T cells (1, 2). Another population of DCs also exists
in peripheral blood, where they represent 
 
z
 
0.5% of the
circulating PBMCs (3). Extensive study of blood DCs has
been limited by their paucity. This population expresses
HLA-DR and lacks specific lineage markers or surface acti-
vation molecules found on other leukocytes. Although
they lack the typical dendritic morphology of mature DCs,
they can rapidly acquire these features in culture (3, 4).
A physiological role for blood DCs is unclear, but at least
some of these cells are hypothesized to be en route to tis-
sues (3, 4). As such, they must be capable of initiating inter-
actions with vascular endothelium while moving in the
blood flow. However, this hypothesis has never been di-
rectly tested and the mechanisms regulating this putative
process are undetermined (3). The extravasation of leuko-
cytes across endothelia has been described as a multistep
cascade of discrete events (5, 6). The initial adhesive step,
which involves binding in shear flow, has been associated
with a limited subset of surface molecules, including the se-
lectins and the 
 
a
 
4 integrins and their respective ligands. In
this study, we examine the capacity of blood DCs to com-
plete the initial step involved in leukocyte homing by teth-
ering and rolling under flow, both in vitro and in vivo
along the skin vessel surface. We further test the capacity of
DCs to extravasate in vivo in the setting of inflammation.
 
Materials and Methods
 
Isolation of Fresh Blood DCs.
 
PBMCs were isolated by density
gradient separation from blood cells collected from normal do-
nors during platelet pheresis. Fresh blood DCs were isolated from
 
1
 
Abbreviations used in this paper:
 
 CLA, cutaneous lymphocyte-associated
antigen; DC, dendritic cell; PSGL-1, P-selectin glycoprotein ligand 1;
VCAM-1, vascular cell adhesion molecule 1; VLA-4, very late antigen 4. 
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PBMCs as described previously (7) or using a commercial blood
DC isolation kit (Miltenyi Biotec). Both methods resulted in very
pure populations of DCs (HLA-DR
 
1
 
 TCR-
 
a
 
/
 
b
 
2
 
, CD14
 
2
 
,
CD56
 
2
 
, and CD19
 
2
 
; see Fig. 1). Viability was 
 
.
 
95% by trypan
blue exclusion. Fresh blood DCs isolated by either method were
used within 4 h of purification.
 
Isolation and Culture of Human CD34
 
1
 
 Hematopoietic Progenitor
Cells.
 
When our experiments required quantities of DCs be-
yond our means to isolate directly from blood (i.e., for the mo-
lecular characterization of selectin ligands expressed on DCs), we
used immature cultured DCs, derived from cord blood progeni-
tors (8). CD34
 
1
 
 progenitors were isolated from the mononuclear
fraction of heparinized umbilical cord blood samples by magnetic
separation (CD34
 
1
 
 separation kit; Miltenyi Biotec). Cell prepara-
tions were routinely 
 
.
 
90% CD34
 
1
 
 by FACS
 
®
 
 with viability ap-
proaching 100%. Cultures of CD34
 
1
 
 progenitors were estab-
lished by seeding at 10
 
5
 
 cells/ml in RPMI 1640 (GIBCO BRL)
supplemented with 10% fetal bovine serum, recombinant human
(rh)GM-CSF (1,000 U/ml; Immunex Corp.), IL-4/TNF-
 
a
 
 (50
U/ml each, R & D Systems), Flt3 ligand (100 ng/ml; Immunex
Corp. and R & D Systems), 10 mM Hepes, 2 mM 
 
l
 
-glutamine,
5 
 
3 
 
10
 
2
 
5
 
 M 2-ME, penicillin (100 U/ml), and streptomycin (100
 
m
 
g/ml). Clusters of nonadherent cells with dendritic morphology
appeared after 4–5 d of culture and increased in number and size
in the following days. We routinely observed a 10–150-fold in-
crease in total cell number after 2–3 wk of culture. Cells were
used on days 10–14 when cultures contained cells with dendritic
phenotypic characteristics and surface markers (72–85% HLA-
DR
 
1
 
, 30–80% CD1a
 
1
 
, 40–50% CD80
 
1
 
, 30–40% CD83
 
1
 
,
 
.
 
95% CD14
 
2
 
).
 
Preparation of Murine Bone Marrow–derived DCs.
 
Bone marrow–
derived DCs were prepared as published previously (9). In brief,
bone marrow cells from FVB mice were depleted of red cells by
lysis in ACK lysing buffer (0.15 M NH
 
4
 
Cl, 1 mM KHCO
 
3
 
, 0.1
mM Na
 
2
 
EDTA, pH 7.3), and the cultures were established in
RPMI 1640 (GIBCO BRL) supplemented with 10% fetal bovine
serum with recombinant murine (rm)GM-CSF (400 U/ml) and
rmIL-4 (150 U/ml; PharMingen). DCs were used between 4 and
6 d after bone marrow harvest. Flow cytometry was performed
immediately before the homing experiments and showed imma-
ture phenotype DCs expressing class II I-A antigen and moderate
amounts of CD40 and B7-2.
 
FACS
 
®
 
 Analysis.
 
mAbs used included HECA-452 (Phar-
Mingen), anti–human P-selectin glycoprotein ligand 1 (PSGL-1)
(PSL-275 and 4H10; gifts from the Genetics Institute, Cambridge,
MA), anti-CD14, anti-CD19, anti-CD56, and anti–TCR-
 
a
 
/
 
b
 
(Coulter Corp.), anti–mouse I-A, anti-CD40, and anti–B7-2 (Phar-
Mingen). Nonbinding isotype-matched antibodies were used as
control reagents. Flow cytometry was performed on a FACScan
 
®
 
IV (Becton Dickinson) using CellQuest software (version 1.2).
Results are representative of multiple independent experiments.
 
Immunoblotting.
 
HECA-immunoreactive DCs were posi-
tively selected from CD34
 
1
 
-derived DCs after 9–10 d of culture
using magnetic microbeads (Miltenyi Biotec) as published previ-
ously (10). Methods for preparing cell lysates from cultured DCs
and for immunoblotting under normal and enhanced reducing
conditions were as described previously (10) with the following
modifications: the anti–PSGL-1 mAb PL1 (mIgG1; Immuno-
tech) was used at a concentration of 2 
 
m
 
g/ml. HECA-452 (a gift
from Dr. L. Picker, University of Texas/Southwestern, Dallas,
TX [11]) was used at 1.2 
 
m
 
g/ml (rather than 2 
 
m
 
g/ml). Immuno-
blots were prepared using 300 
 
m
 
g of HECA-immunoreactive DC
lysate protein per lane for HECA-452 blots and 600 
 
m
 
g of unse-
lected DCs per lane for PSGL-1 blots. Enhanced reduction of cell
lysates was carried out for 5–8 d, rather than 3 d, before SDS-
PAGE.
 
In Vitro Flow Analysis.
 
For E- and P-selectin binding analysis,
cells were analyzed in a parallel plate flow chamber using protein
A–bound E- or P-selectin IgG chimeras as described previously
(12). Washed cells were resuspended in medium with 2 mM
Ca
 
2
 
1
 
 immediately before use, perfused into the chamber, and al-
lowed to interact under static conditions for 3 min. Flow was ini-
tiated at a wall shear stress of 1 dyn/cm
 
2
 
, and interactions were
observed for an additional 1 min. Shear was subsequently in-
creased in a stepwise fashion every 10–30 s, and the percentage of
rolling cells remaining bound was determined at each step. Non-
specific binding was defined as cells remaining bound in 5 mM
EDTA perfused at 50 dyn/cm
 
2
 
. The percentage of cells able to
form adhesions was calculated as the number of cells remaining
bound at 1 dyn/cm
 
2
 
 after a 3-min static incubation, divided by
the number of cells present just before reinitiating flow. The
number of cells attached/
 
m
 
m
 
2
 
/min was determined by counting
the number of new tethers observed in the field during 1 min of
flow at 1 dyn/cm
 
2
 
.
 
Intravital Microscopy.
 
Normal adult Swiss Webster mice, mice
deficient in both E- and P-selectin (E/P-selectin
 
2
 
/
 
2
 
; reference
13), and control wild-type mice from the same strain as the defi-
cient mice (C57BL/129SV) were anesthetized by intraperitoneal
injection of saline (10 ml/kg) containing 5 mg/ml ketamine and
1 mg/ml xylazine. The hair on the left ear as well as on the sub-
mandibular area of the neck was removed using hair removal lo-
tion. A PE-10 polyethylene catheter was inserted into the right
common carotid artery of a thermo-controlled mouse whose left
ear was covered with glycerol and gently positioned between a
microscope slide and a coverslip under an intravital microscope
(model IV-500; Mikron Instruments). DCs were fluorescently la-
beled (2.5 
 
m
 
g calcein/ml/10
 
7
 
 cells; Molecular Probes, Inc.) and
introduced by retrograde injection into the right carotid artery.
Fluorescent DCs in ear microvessels were visualized by strobo-
scopic fluorescent epi-illumination using infinity-corrected wa-
ter-immersion optics (Carl Zeiss) and a silicon-intensified target
camera (Dage). Rolling fractions were determined as the percent-
age of interacting cells in the total flux of fluorescent DCs that
passed through each venule during the same period. The veloci-
ties of individual rolling cells were determined by off-line analysis
of videotapes using a PC-based interactive image analysis system
(14). Hemodynamic parameters were determined in 3 animals, 4
venules, and 82 noninteracting cells (12, 12, 28, and 30 fast cells
per venule) for cultured DCs in wild-type mice; in 3 mice, 3
venules, and 96 cells (31, 32, and 33 per venule) for cultured DCs
in E/P-selectin
 
2
 
/
 
2
 
 mice; and in 2 wild-type mice, 3 venules, and
55 cells (18, 18, and 19 per venule) for freshly isolated DCs.
Anti–mouse E- and P-selectin blocking antibodies, 9A9 and
5H1, respectively (from B. Wolitzky, Hoffman-La Roche, Inc.,
Nutley, NJ), were used at 100 
 
m
 
g/mouse and injected into the
blood circulation 5 min before the infusion of the cells.
 
Homing of DCs during a Hypersensitivity Contact Reaction in
Mice.
 
FVB mice were sensitized with a classical contact sensi-
tizer, oxazolone (100 
 
m
 
l of 2% oxazolone in acetone on abdomi-
nal skin) 6 d before challenge with 10 
 
m
 
l of 0.8% oxazolone on
both sides of the right ear. The left ear was not treated and is re-
ferred to as the control ear. Immature bone marrow–derived DCs
were labeled with 
 
51
 
Cr (NEN) as follows: 10
 
7
 
 DCs/ml were re-
suspended in RPMI containing 20% FCS and incubated for 1 h
with 200–400 
 
m
 
l of [
 
51
 
Cr] sodium chromate (1 mCi/ml) at 37
 
8
 
C
in 5% CO
 
2
 
. The cells were washed twice in RPMI, and 5 
 
3 
 
10
 
6 
629
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DCs/mouse were infused into the tail vein 48 h after the chal-
lenge was applied. The mean specific radioactivity of injected
DCs was 288 cpm/10
 
3
 
 cells (range 88–620). 6 h after DC infu-
sion, the mice were killed, and the radioactivities of both ears
were counted in a gamma counter.
Calcein-labeled DCs were also used in similar experiments.
100 
 
m
 
g of PE-conjugated CD31 mAb (PharMingen) was infused
into the tail veins of mice 5 min before they were killed in order
to visualize the vessels by confocal microscopy. Ears were split in
two halves parallel to their broad surfaces using fine forceps, put
between a microscope slide and a coverslip, and examined using a
BioRad MRC-1024 confocal imaging system.
 
Results
 
DCs Uniformly Express the Selectin Ligand PSGL-1/Cuta-
neous Lymphocyte-associated Antigen.
 
Magnetic separation of
blood DCs allowed the recovery of 
 
.
 
85% pure DCs, as de-
fined by the expression of HLA-DR and the lack of specific
lineage markers CD14, CD56, CD19, and TCR-
 
a
 
/
 
b
 
 (Fig.
1). We examined DC expression of three leukocyte cell sur-
face molecules known to mediate binding under physiologic
flow conditions: PSGL-1, L-selectin, and the integrin 
 
a
 
4
 
b
 
1.
Roughly 50% of freshly isolated DCs expressed L-selectin
(not shown), whereas 
 
a
 
4
 
b
 
1 (not shown) and PSGL-1 (Fig. 2
a) were expressed by 100% of the cells. We had previously
shown that PSGL-1 on T cells could be expressed in an
uniquely glycosylated form that reacts with an oligosaccha-
ride-specific antibody called HECA-452 and binds to both E-
and P-selectin under flow (10, 11, 15). When expressed on
memory T cells, this isoform of PSGL-1 is known as cutane-
ous lymphocyte-associated antigen (CLA [10]) and is thought
to direct the extravasation of T cells into inflamed skin.
Although HECA-452 immunoreactivity has been shown
on Langerhans cells, a subset of DCs (16, 17), neither the
Figure 1. Blood DCs express HLA-DR but do not express specific lin-
eage markers CD14, CD19, or CD56 or any TCR (reference 3). (a)
They represent ,1% of the PBMCs (reference 3). After immunomag-
netic depletion of T cells, monocytes, and NK cells, using CD3, CD11b,
and CD16 antibodies and positive selection of CD41 leukocytes (blood
DC isolation kit from Miltenyi Biotec), a population of .90% pure blood
DCs is obtained (b).
Figure 2. (a and b) Freshly isolated DCs homogeneously express P- and E-selectin ligand, PSGL-1/CLA. FACS® analysis of cultured DCs stained with
mAb to PSGL-1 (PSL-275) and to CLA (HECA-452). (c) Cultured DCs express PSGL-1 (4H10), and 30% (30–50%) of them also express CLA. (d and
e) Immunoblotting of cultured DC lysates with anti–PSGL-1 (d) and HECA-452 (e) shows that the CLA epitope is expressed on a single glycoprotein.
Analysis under standard reducing conditions (lane 1) revealed specific immunoreactive bands at 240 kD (dimer) and 140 kD (monomer) with each spe-
cific antibody; and under enhanced reducing conditions (lane 2), only one specific band at 140 kD (monomer) was seen for both HECA-452 and anti–
PSGL-1 immunoreactivities. The bands at 50 and 60 kD in the HECA-452 blot represent the HECA antibody used for immunomagnetic separation, as
shown previously (reference 10). 
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structure of the molecules carrying this oligosaccharide
epitope nor its functional capability as a selectin ligand on
DCs has been reported. FACS
 
®
 
 analysis was performed us-
ing 4H10 or PSL-275, two mAbs that recognize peptide
determinants in the P-selectin binding domain of PSGL-1,
and HECA-452, an IgM mAb that recognizes a carbohy-
drate epitope similar to sialyl Lewis X (18) and defines CLA
expression on T cells (11). PSGL-1 and CLA were ex-
pressed by virtually all freshly isolated blood DCs (Fig. 2, a
and b). PSGL-1 was also homogeneously expressed on ex
vivo
 
–
 
derived DCs (cultured for 10–14 d), whereas HECA-
452 was expressed on only a subset of these cells (25–40%;
Fig. 2 c). To further characterize the structure of these
molecules on DCs, immunoblotting of cell lysates with
HECA-452 and anti–PSGL-1 antibodies was performed
(Fig. 2, d and e). Both antibodies recognized bands of
 
z
 
240 and 140 kD under normal reducing conditions, rep-
resenting the dimeric and monomeric forms of CLA/
PSGL-1 as described previously (10). Enhanced reduction
resulted in conversion of all immunoreactivity to a single
band of 140 kD, indicating that in DCs, as in T cells, the
epitope recognized by HECA-452 is expressed on only a
single major surface glycoprotein, PSGL-1.
 
DCs Tether and Roll on Both E- and P-selectin In Vitro.
 
Having identified a candidate ligand for E- and P-selectin,
the ability of these cells to tether and roll on both E- and
P-selectin was assessed in vitro using a parallel plate flow
chamber (19). HL60 cells, a promyelocytic cell line known
to bind to E- and P-selectin (20), were included as a con-
trol. DCs bound to both E-selectin and P-selectin with
high affinity and rolled in shear flow (Fig. 3, a and b). The
percentage of cells interacting with E- or P-selectin after 3
min of static incubation varied between 77 and 94%. Resis-
tance to detachment from E- and P-selectin during step-
wise increases in shear flow was extremely high (Fig. 3, c
and d). Even at a wall shear stress as high as 100 dyn/cm
 
2
 
,
 
.
 
50% of the tethered cells remained bound and rolling.
No significant differences were observed between fresh
and cultured DCs within the physiologic shear range of
postcapillary venular blood flow (1–25 dyn/cm
 
2
 
). How-
ever, at high shear stresses (50–100 dyn/cm
 
2
 
) fresh DCs
showed an increased shear resistance compared with cul-
tured DCs (Fig. 3, c and d).
 
DCs Tether and Roll on Endothelium of Noninflamed Skin.
 
While the parallel plate flow chamber assay is a useful
model for assessment of distinct adhesion pathways under
defined shear flow conditions, the advent of intravital mi-
croscopy has made possible the direct observation of leuko-
cyte interaction with postcapillary venular endothelium in
vivo (14). The ability of human E- and P-selectin ligands
to interact effectively with murine selectins allows human
leukocytes to be studied in mouse microvessels (Stein, J.,
and U.H. von Andrian, unpublished data). Selectin-depen-
dent rolling of leukocytes has been observed in mouse skin
microcirculation without surgical manipulation of the tis-
sue, thus allowing observation of basal interactions between
leukocytes and noninflamed endothelium (21; and Ulfman,
L.H., and U.H. von Andrian, manuscript submitted for
publication). We tested the hypothesis that the high level
of CLA/PSGL-1 expression on blood DCs would permit
tethering and rolling of these cells in uninflamed ear post-
capillary venules. Fluorescently labeled human DCs were
injected through the right common carotid artery into the
aortic arch of anesthetized mice and observed directly in
the microcirculation of the left ear. In the absence of any
overt skin inflammation, a significant fraction of injected
blood DCs were observed to tether and roll in cutaneous
microvessels in vivo
 
 
 
(Table I). Injected cells interacted ex-
clusively with postcapillary venules, where the extravasa-
tion of other leukocytes is known to take place (22), and
not with arterioles or capillaries (Fig. 4 a). A significant
proportion of cultured DCs also rolled in murine ear post-
capillary venules, and displayed comparable rolling proper-
ties (Table I).
 
Interaction of DCs with Endothelium In Vivo Is Mediated by
Endothelial Selectins.
 
To assess the role of endothelial se-
lectins in DC binding to postcapillary venules, we per-
formed experiments in the presence of blocking antibodies
as well as in E/P-selectin
 
2
 
/
 
2 
 
animals (13). As shown in Ta-
ble I, pretreatment with anti–E- and P-selectin mAbs effec-
tively blocked interaction of DCs with skin vessels. Objec-
tive assessment of leukocyte endothelial interaction was
obtained by comparing the velocity distribution of cells ob-
Figure 3. DCs tether and roll on E- and P-selectin in vitro. Interaction
of DCs with E- and P-selectin was assessed in a parallel plate flow cham-
ber. HL60 cells are included as a positive binding control. Both fresh and
cultured DCs formed tethers on E-selectin (a) and P-selectin (b) at 1 dyn/
cm2 and rolled in a calcium-dependent fashion. DCs bound to either E-
(c) or P-selectin (d) showed strong resistance to detachment by increasing
wall shear stress with .80–100% of cells remaining bound at 25 dyn/cm2.
E- and P-selectin binding was abolished by perfusion of medium contain-
ing 5 mM EDTA. The data presented are the mean and range of two ex-
periments and are representative of several independent observations.631 Robert et al.
served in comparable size vessels in E/P-selectin2/2 and
control mice (Fig. 4 b). Cells traveling below Vcrit, the cal-
culated velocity of noninteracting cells at the endothelial
surface of a blood vessel with a parabolic flow profile (22),
are defined as interacting with (i.e., rolling on) the vessel
walls while the cells moving above Vcrit are traveling free in
the bloodstream. Although z50% of labeled DCs observed
in the vessels of wild-type mice formed rolling interactions,
Table I. DC Rolling Parameters in Ear Venules
Fresh DCs Cultured DCs
No Antibody Plus antibodies* Wild-type mice E/P-selectin2/2 mice
No. of animals/venules/cells 3/31/534 2/14/241 5/27/627 3/31/96
Rolling fraction (%) 26.5 6 7.5 0.01 6 0 50 6 12.4 0.3 6 0
Mean rolling velocity (mm/s) 59.8 6 35.4 — 57.8 6 4—
Mean blood flow velocity (mm/s) 1,549 6 633 ND 1,294 6 264 1,434 6 563
Wall shear rate (s21) 406 6 228 ND 339 6 78 253 6 39
Shear stress (dyn/cm2) 10.1 6 5.7 ND 8.5 6 2 6.3 6 1
Rolling fractions were obtained from the numbers of cells and venules indicated in the table. Hemodynamic parameters were determined in 2 ani-
mals, 3 venules, and 55 noninteracting cells for freshly isolated DCs; 4 animals, 4 venules, and 82 noninteracting cells for cultured DCs in wild-type
mice; and in 2 animals, 2 venules, and 96 noninteracting cells for the E/P-selectin2/2 mice and were calculated as described previously (reference
22). Centerline blood flow velocity (VCL) was calculated from the velocity of the fastest cell traversing the field during the period of observation. The
mean blood flow velocity was estimated assuming a parabolic flow profile as Vblood 5 VCL/1.6. The wall shear stress was approximated from the wall
shear rate assuming the viscosity of blood to be 0.025 poise.
*100 mg of anti–mouse E- and P-selectin blocking antibodies (9A9 and 5H1, respectively; provided by B. Wolitzky) was injected per mouse.
Figure 4. (a) DCs tether and roll in murine ear postcapillary venules in
vivo. Calcein-labeled DCs were observed in ear postcapillary venules (top
panel) after carotid injection. Continuous observation of bound cells (rep-
resentative examples identified by arrowheads) reveals considerable heter-
ogeneity of individual velocities. Three cells identified in the top panel are
observed to move significantly different distances over the 1-min period
of observation. All other cells shown have rolled out of the field of view
during the 1-min interval. During that same period, several additional
rolling cells have appeared (bottom panel). Unbound cells moved through
the field of view within ,1 s (not shown). The large bright areas seen be-
tween vessels are autofluorescent hair follicles. Bar, 100 mm. (b) Attach-
ment and rolling of cultured DCs in wild-type mice (51 cells in a 28-mm-
diameter venule; mean blood flow velocity 5 890.6 mm/s, Vcrit 5 388.2
mm/s) and E/P-selectin double-deficient mice (64 cells in a 34-mm-diam-
eter venule; mean blood flow velocity 5 1,281 mm/s, Vcrit 5 471.7 mm/
s). Vcrit, the velocity of an idealized noninteracting cell (i.e., moving freely
with the bloodstream) traveling at the vessel wall, was calculated as de-
scribed (reference 22). DCs were not observed to form productive attach-
ments in E/P-selectin2/2 mice, where all cells (solid line) traveled at ve-
locities greater than Vcrit, whereas z53% of cells observed in wild-type
mice (dashed line) rolled at velocities less than Vcrit.632 Interaction of Dendritic Cells with Skin Endothelium
no significant interactions were observed in endothelial se-
lectin–deficient animals (,0.5% labeled cells traveling be-
low  Vcrit). Besides E- and P-selectin ligands, the only
known leukocyte adhesion molecules capable of mediating
tethering and rolling on vascular endothelium are L-selec-
tin, very late antigen 4 (VLA-4) and a4b7. The vascular
ligands for L-selectin and integrin a4b7, peripheral lymph
node addressin (PNAd) and mucosal addressin cell adhesion
molecule 1 (MAdCAM-1), respectively, are not expressed
in normal skin endothelium (23, 24) and therefore would
not be expected to participate in these interactions. How-
ever, murine vascular cell adhesion molecule 1 (VCAM-1)
may be present, and can readily bind human VLA-4 (inte-
grin a4b1 [25]). The lack of interactions observed in anti-
selectin antibody–blocked or selectin-deficient animals un-
ambiguously indicates that the spontaneous tethering and
rolling of DCs observed in wild-type animals is mediated
by one or both of the endothelial selectins constitutively
expressed on skin postcapillary venules, and that a major
role for other known ligand pairs can be excluded, at least
in the dermal vascular bed studied here. We cannot rule
out unknown or uncharacterized ligand pairs that do not
bind across species. However, these data are consistent with
observations in rats, mice, and rabbits that the constitutive
rolling of endogenous leukocytes in skin venules is medi-
ated primarily via interaction with vascular selectins (26,
27; and Ulfman, L.H., and U.H. von Andrian, manuscript
submitted for publication), and not via a4 integrins, or
L-selectin, in contrast to other anatomic sites such as bone
marrow (28) or peripheral lymph nodes (29).
DCs Are Recruited into Inflamed Skin. Endothelial selec-
tins and other adhesion molecules involved in leukocyte
recruitment are upregulated during cutaneous inflamma-
tion (30). Since blood DCs express functional selectin
ligands, chemokine receptors, and cell surface integrins (2,
3, 7), they should have all the requisite molecules necessary
for recruitment into inflamed tissues. To test whether DCs
could be recruited to inflamed skin, we measured accumu-
lation of radioactively labeled DCs in ear skin of ox-
azolone-sensitized mice challenged with antigen on one ear
48 h before the infusion of the cells. To avoid potential in-
compatibility between human and mouse elements in the
downstream portions of the adhesion/extravasation cas-
cade, we used immature murine bone marrow–derived
DCs, grown for 4–6 d with GM-CSF and IL-4 (9). 51Cr-
labeled DCs (mean specific activity 5 288 cpm/103) were
injected intravenously, and the mice were killed 6 h later.
Radioactivity counts were significantly higher in inflamed
ears compared with control ears (cpm ratio in challenged
versus control ears ranged from 1.7 to 9; mean ratio 5 3.5,
P , 0.01; Fig. 5, a and b). Cells recovered in inflamed ears
ranged from 0.02 to 0.25% of injected cells or 103 to 1.25 3
104 cells/ear. This is consistent with previous reports of
cells recovered from significantly larger areas of inflamed
skin samples after intravenous injection of radiolabeled T
cells (31, 32). A trivial explanation would be that this in-
crease in cpm resulted from an increase of the volume of
blood in the inflamed ear, and not from extravasation of
DCs. One argument against this explanation is that this
phenomenon required living cells, since no specific label
was found in the skin after injection of dead DCs (not
shown). To confirm that this increase in radioactivity actu-
ally represented extravasated DCs, we performed similar
experiments with calcein-labeled DCs and injected PE-
conjugated anti–mouse CD31 mAb 5 min before the ani-
mals were killed, to stain the vessels in red. Confocal
microscopy of inflamed ears showed extravascular DCs
(green) clearly outside of the skin vessels and in the ex-
travascular tissue (Fig. 5, c–e), confirming the actual ex-
travasation of the DCs, whereas no extravascular cells were
observed in noninflamed ears. It should be emphasized that
this experiment was designed to be purely qualitative and
to address the anatomical location rather than absolute
number of extravasated cells.
Discussion
In this study, we have shown that DCs efficiently tether
and roll on E- and P-selectin in vitro. Taking advantage of
previous studies showing that relevant adhesion molecules
which mediate leukocyte rolling (i.e., selectins/selectin
ligands and VLA-4/VCAM-1) are functional across human
and murine species (25; and Stein, J., and U.H. von An-
drian, unpublished data), we have demonstrated a direct in-
teraction between human DCs and murine skin postcapil-
lary venules in vivo. This confirms the hypothesis that DCs
can participate in the essential first step of the adhesion/
extravasation pathway on vessels expressing E- and/or
P-selectin. This interaction takes place in the absence of
overt inflammation and may also facilitate the extravasation
of DCs into injured skin. To undergo extravasation, rolling
cells have to be activated (e.g., by chemoattractants) and to
bind via surface integrins to vascular cell adhesion mole-
cules (e.g., intercellular adhesion molecule 1 [ICAM-1]
and VCAM-1). DCs express multiple chemokine receptors
(7, 33, 34). As described previously for different types of
lymphocytes (35), it was recently shown that DCs at differ-
ent maturational stages express patterns of chemokine re-
ceptors that seem to correlate with recruitment to distinct
anatomic sites (36–38). DCs also express the cell surface in-
tegrins LFA-1 and VLA-4 (2, 3), the ligands for ICAM-1
and VCAM-1, respectively. Thus, DCs appear to have all
the surface molecules required to participate in the adhe-
sion/extravasation cascade. We have confirmed this poten-
tial by demonstrating active recruitment of immature cul-
tured DCs into inflamed skin after intravenous injection
and by direct visualization of extravasated DCs using con-
focal microscopy. These experiments were highly repro-
ducible despite the low absolute number of cells found in
ear skin. The association between skin homing potential
and in vivo rolling on murine skin venules is strengthened
by the observation that naive lymphocytes, which do not
express PSGL-1/CLA and do not normally migrate to skin
(15), do not show significant interaction with murine skin
endothelium in vivo. In contrast, T cells isolated from a cu-
taneous T cell lymphoma patient, which express PSGL-1/633 Robert et al.
CLA at high levels and do target to skin, roll spontaneously
on uninflamed mouse ear postcapillary venules (Robert,
C., unpublished data).
There are at least two non-mutually exclusive reasons
why blood DCs should be able to migrate to peripheral tis-
sues. First, they may represent a pool of tissue DC precur-
sors that continuously extravasate to repopulate tissues with
resident DCs (e.g., for skin, the dermal DCs and/or the
Langerhans cells). Second, blood DCs may also represent a
circulating pool of APCs that are acutely recruited to sites
of inflammation. Consistent with this hypothesis, it has
been reported that the number of DCs is increased in tis-
sues in different models of inflammation (39–41), though
DCs have never been shown to be actively recruited from
the blood.
We showed that blood DCs constitutively interact with
normal murine skin endothelium in vivo via selectins. This
spontaneous rolling of CLA1 DCs in skin microvessels, in
the absence of an inflammatory stimulus, suggests that a
large number of blood DCs may be interacting with cuta-
neous postcapillary venules at any given time. This contin-
uous interaction is likely to play a role in the seeding of pe-
ripheral tissues with DCs to provide the tissue-resident
pool of APCs. We also showed that DCs can be acutely re-
Figure 5. Immature murine
bone marrow–derived DCs are
acutely recruited into inflamed
skin. Mice sensitized to oxazo-
lone were challenged on the
right ear 48 h before intravenous
infusion of 5 3 106 51Cr-labeled
DCs. 6 h after DC infusion, the
mice were killed and the cpm
were compared in both ears. (a)
Results obtained in nine mice
are shown; cpm values are cor-
rected by subtraction of the
background radioactivity. There
is a significant difference be-
tween the challenged and con-
trol ear (P , 0.01, Student’s t
test). (b) Shows the fold increase
in cpm measured in inflamed
ears versus contralateral control
ears for nine independent deter-
minations. The area from 0 to 1
is shaded. Values above the
shaded area reflect an increased
number of labeled cells in the in-
flamed ear, and values within the
shaded area would reflect a de-
creased number of cells in the in-
flamed ear relative to control.
The solid line and hatched field
represent the mean and 95%
confidence interval for fold in-
crease of inflamed ear counts
versus control (P , 0.01, Stu-
dent’s t test). (c–e) Confocal mi-
croscopy images of an inflamed
ear 6 h after infusion of 20 3 106
calcein-labeled murine bone
marrow–derived DCs. 100 mg of
PE-conjugated mAb anti–mouse
CD31 (PharMingen) was infused
5 min before the animal was
killed, in order to visualize the
vessels. Several fields of the same
ear (photographed through a
403 objective) are shown: (c) a
calcein-labeled DC is seen just
outside of the vessel wall; (d) an-
other DC is seen between two
small vessels; and (e) a calcein-
labeled DC has clearly extrava-
sated and is shown deeper in the
surrounding tissues. No extravas-
cular cells were observed in con-
tralateral, noninflamed ear.634 Interaction of Dendritic Cells with Skin Endothelium
cruited into inflamed skin. We propose that constitutive se-
lectin-mediated rolling represents surveillance of the lumi-
nal aspect of skin endothelium by blood DCs for activating
signals (e.g., chemokines). This enhances the ability of
these potent APCs to rapidly extravasate when they en-
counter inflamed endothelium, as in the setting of skin in-
jury or infection. Rapid recruitment of blood DCs, facili-
tated by these constitutive reversible interactions between
blood DCs and endothelial surfaces, could enhance local
antigen capture and antigen presentation activity both at
the site of inflammation and in the draining lymph nodes.
Teleologically, this may represent a previously unrecog-
nized element of skin immunosurveillance and a highly
adaptive interface between innate and acquired immunity.
It is interesting to note that DCs are often referred to as
“nature’s adjuvant” (1). The rapid recruitment of APCs to
sites of inflammation may be an important element in de-
termining the efficiency of primary immune responses, as
seen, for example, in the enhancing effect of adjuvant-
induced inflammation on the response to immunization.
The relative importance of rapid recruitment of DCs and
monocytes in this process is at present unknown. We favor
the hypothesis that DCs provide an immediate bolus of
APCs that can present antigens to CLA1 memory T cells
that have extravasated under similar conditions in inflamed
skin. Monocytes also express PSGL-1/CLA and can tether
and roll on E- and P-selectin in vitro (Kieffer, J.D., unpub-
lished data). They can differentiate into DCs in vitro (42)
but require at least 48 h to do so, and therefore may be
more important in the amplification and perpetuation of
the immune response. These hypotheses are currently be-
ing tested experimentally.
In summary, we show that immature blood DCs can
participate in the leukocyte adhesion/extravasation path-
way and be acutely recruited to inflamed skin. Constitutive
interactions between DCs and normal skin endothelium
may represent an important immunosurveillance mecha-
nism by which DCs could sample local activating signals
and rapidly extravasate into inflamed tissues.
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